Biotech Week Boston

@BiotechWkBoston

Where Big Science and Bright Minds Meet. Join us Sep 21-24, 2020 at BCEC.

Vrijeme pridruživanja: srpanj 2016.

Tweetovi

Blokirali ste korisnika/cu @BiotechWkBoston

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BiotechWkBoston

  1. Prikvačeni tweet

    We hope you enjoyed and took home a feast of insights. We'll have more exciting things in store for next year. Save the date!

    Poništi
  2. 31. sij

    Where do you start in setting up manufacturing for a new therapy? Insourcing or outsourcing - and when is best to decide? This whitepaper presents best practices and case studies.

    Poništi
  3. 29. sij

    When developing a new therapy how do you keep in complete control of its manufacturing? This whitepaper looks at what to consider - whatever path you take.

    Poništi
  4. 28. sij

    How are leading biotech and pharma organizations successfully implementing initiatives? Here are 6 best practices chosen by Edie Stringfellow

    Poništi
  5. 26. sij

    We look at 6 practical ways and companies can implement , as presented by Edie Stringfellow at this year's

    Poništi
  6. 24. sij

    Edie Stringfellow identifies six best practices that biotech and pharma companies can use to directly improve their workplace culture.

    Poništi
  7. 22. sij

    How are leading biotech and pharma organizations successfully implementing initiatives? Here are 6 best practices chosen by Edie Stringfellow

    Poništi
  8. 20. sij

    We look at 6 practical ways and companies can implement , as presented by Edie Stringfellow at this year's

    Poništi
  9. 18. sij

    Edie Stringfellow identifies six best practices that biotech and pharma companies can use to directly improve their workplace culture.

    Poništi
  10. 16. sij

    How are leading biotech and pharma organizations successfully implementing initiatives? Here are 6 best practices chosen by Edie Stringfellow

    Poništi
  11. 14. sij

    We look at 6 practical ways and companies can implement , as presented by Edie Stringfellow at this year's

    Poništi
  12. 13. sij

    Dr Satish Nadig, Endowed Chair in Solid Organ Transplantation at the Medical University of South Carolina, discusses how industry collaborations are impacting his work and what's next for the organ transplant program at MUSC

    Poništi
  13. 12. sij

    Edie Stringfellow identifies six best practices that biotech and pharma companies can use to directly improve their workplace culture.

    Poništi
  14. 10. sij

    Chris Gemmiti, VP of Operations gave his take on the future of Mesenchymal and top 3 triumphs in cell and gene therapies to date.

    Poništi
  15. 10. sij

    How are leading biotech and pharma organizations successfully implementing initiatives? Here are 6 best practices chosen by Edie Stringfellow

    Poništi
  16. 9. sij

    Dr Satish Nadig, Endowed Chair in Solid Organ Transplantation at the Medical University of South Carolina, discusses how industry collaborations are impacting his work and what's next for the organ transplant program at MUSC

    Poništi
  17. 8. sij

    We look at 6 practical ways and companies can implement , as presented by Edie Stringfellow at this year's

    Poništi
  18. 6. sij

    Edie Stringfellow identifies six best practices that biotech and pharma companies can use to directly improve their workplace culture.

    Poništi
  19. 5. sij

    Dr Satish Nadig, Endowed Chair in Solid Organ Transplantation at the Medical University of South Carolina, discusses how industry collaborations are impacting his work and what's next for the organ transplant program at MUSC

    Poništi
  20. 4. sij

    Chris Gemmiti, VP of Operations gave his take on the future of Mesenchymal and top 3 triumphs in cell and gene therapies to date.

    Poništi
  21. 4. sij

    How are leading biotech and pharma organizations successfully implementing initiatives? Here are 6 best practices chosen by Edie Stringfellow

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·